Clinical Trial: SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Smith-Lemli Opitz Syndrome: A Clinical Investigation of the Effect of Simvastatin in Patients Receiving Cholesterol Supplementation

Brief Summary: The purpose of this study is to determine if simvastatin improves development and behavior in patients with Smith Lemli-Opitz syndrome (SLOS) receiving dietary cholesterol supplementation.